Sildenafil Added Effect in Dapoxetine Non-responding Mono-symptomatic Premature Ejaculation (PE)

• Status: Not yet recruiting
• Trial end date: 2023-11-01
• Target enrollment: 0
• Participant gender: Male

Summary

Study Design: Single Blind Placebo Controlled Randomized Trial, aiming to assess the efficacy and safety of adding sildinafile 50 mg to dapoxitine 30 mg in dapoxitine non responding premature ejaculation.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Al-Azhar University
• Treatments: Sildenafil Citrate

Criteria

Inclusion Criteria:

• Male patients, age ≥20 years old, married and/or in a stable regular sexual relationship for at least 3 months before the study.

Exclusion Criteria:

• - Men with associated erectile dysfunction (ED).

• Men with associated chronic prostatitis.

• Diabetes Mellitus (DM).

• Advanced renal or hepatic diseases.

• Neurological diseases and C.N.S. medications.